KR860002574A - 항생물질 at 2433 복합체의 제조방법 - Google Patents
항생물질 at 2433 복합체의 제조방법 Download PDFInfo
- Publication number
- KR860002574A KR860002574A KR1019850006663A KR850006663A KR860002574A KR 860002574 A KR860002574 A KR 860002574A KR 1019850006663 A KR1019850006663 A KR 1019850006663A KR 850006663 A KR850006663 A KR 850006663A KR 860002574 A KR860002574 A KR 860002574A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- compounds
- pharmaceutically acceptable
- preparing
- cultured
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/38—Nucleosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/58—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (3)
- 일반식(Ⅰ)의 화합물을 생성시킬 수 있는 악티노마두라 멜리아우라(Actinomadura melliaura) 균주를 수성 영양 배지내에서 상당량의 항균 활성이 얻어질 때까지 배양하고, 생성된 일반식(Ⅰ)의 화합물을 그대로 또는 약제학적으로 허용되는 염의 형태로 분리함을 특징을 하여, 라세미형 또는 광학적 활성형인 일반식(Ⅰ)의 화합물 및 약제학적으로 허용되는 그의 염을 제조하는 방법.상기식에서, X는 수소 또는 염소이고; R은 수소 또는 CH3이다.
- 제1항에 있어서, (a) 무정형 고체 형태이며 실제로 명세서중의 표 Ⅶ에 기술된 물리적 특성을 갖는, X가 염소이고 R이 CH3인 화합물, AT 2433 A1; (b) 무정형 고체 형태이며 실제로 명세서의 표 Ⅷ에 기술된 물리적 특성을 갖는, X가 염소이고 R이 수소인 화합물, AT 2433 A2; (c) 무정형 고체 형태이며 실제로 명세서의 표 Ⅸ에 기술된 물리적 특성을 갖는, X가 수소이고 R이 CH3인 화합물, AT 2433 B1; (d) 무정형 고체 형태이며 실제로 명세서의 표 X에 기술된 물리적 특성을 갖는, X가 수소이고 R이 수소인 화합물, AT 2433 B2; (e) 상기 4가지 화합물 (a) 내지 (d)로 구성되는 AT 2433 복합체; (f) AT 2433 A1및 AT2433 A2로 구성되는 혼합물; 또는 (g) AT 2433 B1및 AT 2433 B2로 구성되는 혼합물; 및; 약제학적으로 허용되는 그의 염을 제조하는 방법.
- 제1항에 있어서, 악티노마두라 멜리아우라(Actinomadura melliaura) ATCC 39691 및 그의 돌연변이체를 배양하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/651,498 US4743594A (en) | 1984-09-17 | 1984-09-17 | Antibiotic, antitumor compounds and their use |
US651498 | 1984-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR860002574A true KR860002574A (ko) | 1986-04-26 |
Family
ID=24613073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850006663A KR860002574A (ko) | 1984-09-17 | 1985-09-12 | 항생물질 at 2433 복합체의 제조방법 |
Country Status (18)
Country | Link |
---|---|
US (1) | US4743594A (ko) |
EP (1) | EP0175284B1 (ko) |
JP (1) | JPS61106592A (ko) |
KR (1) | KR860002574A (ko) |
AT (1) | ATE42305T1 (ko) |
AU (1) | AU4741785A (ko) |
CA (1) | CA1315230C (ko) |
DE (1) | DE3569538D1 (ko) |
DK (1) | DK415185A (ko) |
ES (1) | ES8703931A1 (ko) |
FI (1) | FI853506L (ko) |
GR (1) | GR852224B (ko) |
HK (1) | HK4992A (ko) |
HU (1) | HU194315B (ko) |
NO (1) | NO853567L (ko) |
PT (1) | PT81118B (ko) |
YU (1) | YU147385A (ko) |
ZA (1) | ZA857003B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3835842A1 (de) * | 1988-10-21 | 1990-04-26 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
US5015578A (en) * | 1989-03-23 | 1991-05-14 | Bristol-Myers Squibb Company | BMY-41950 antitumor antibiotic |
CA2130836A1 (en) * | 1992-03-20 | 1993-09-30 | Martin J. Slater | Further indole derivatives with antiviral activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5918035A (ja) * | 1982-07-20 | 1984-01-30 | Katsuyuki Taniguchi | ダンプ車の荷箱の支点構造 |
US4487925A (en) * | 1983-01-28 | 1984-12-11 | Bristol-Myers Company | Rebeccamycin and process for its preparation |
US4524145A (en) * | 1984-09-04 | 1985-06-18 | Bristol-Myers Company | 4'-Deschlororebeccamycin pharmaceutical composition and method of use |
-
1984
- 1984-09-17 US US06/651,498 patent/US4743594A/en not_active Expired - Fee Related
-
1985
- 1985-09-12 GR GR852224A patent/GR852224B/el unknown
- 1985-09-12 AU AU47417/85A patent/AU4741785A/en not_active Abandoned
- 1985-09-12 AT AT85111531T patent/ATE42305T1/de not_active IP Right Cessation
- 1985-09-12 PT PT81118A patent/PT81118B/pt unknown
- 1985-09-12 KR KR1019850006663A patent/KR860002574A/ko not_active Application Discontinuation
- 1985-09-12 DK DK415185A patent/DK415185A/da unknown
- 1985-09-12 ES ES546915A patent/ES8703931A1/es not_active Expired
- 1985-09-12 DE DE8585111531T patent/DE3569538D1/de not_active Expired
- 1985-09-12 ZA ZA857003A patent/ZA857003B/xx unknown
- 1985-09-12 EP EP85111531A patent/EP0175284B1/en not_active Expired
- 1985-09-12 CA CA000490525A patent/CA1315230C/en not_active Expired - Fee Related
- 1985-09-12 NO NO853567A patent/NO853567L/no unknown
- 1985-09-13 FI FI853506A patent/FI853506L/fi not_active Application Discontinuation
- 1985-09-13 JP JP60203198A patent/JPS61106592A/ja active Granted
- 1985-09-16 HU HU853482A patent/HU194315B/hu not_active IP Right Cessation
- 1985-09-17 YU YU01473/85A patent/YU147385A/xx unknown
-
1992
- 1992-01-16 HK HK49/92A patent/HK4992A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
YU147385A (en) | 1988-06-30 |
ZA857003B (en) | 1986-12-30 |
DK415185D0 (da) | 1985-09-12 |
EP0175284A2 (en) | 1986-03-26 |
CA1315230C (en) | 1993-03-30 |
DE3569538D1 (en) | 1989-05-24 |
HUT42527A (en) | 1987-07-28 |
US4743594A (en) | 1988-05-10 |
HK4992A (en) | 1992-01-17 |
FI853506A0 (fi) | 1985-09-13 |
EP0175284B1 (en) | 1989-04-19 |
PT81118B (en) | 1987-07-06 |
ATE42305T1 (de) | 1989-05-15 |
NO853567L (no) | 1986-03-18 |
GR852224B (ko) | 1986-01-13 |
AU4741785A (en) | 1986-04-24 |
JPS61106592A (ja) | 1986-05-24 |
ES546915A0 (es) | 1987-03-01 |
JPH0558440B2 (ko) | 1993-08-26 |
ES8703931A1 (es) | 1987-03-01 |
DK415185A (da) | 1986-03-18 |
EP0175284A3 (en) | 1986-12-17 |
FI853506L (fi) | 1986-03-18 |
PT81118A (en) | 1985-10-01 |
HU194315B (en) | 1988-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910009729A (ko) | 신규한 폴리펩티드 화합물과 그 제조방법 | |
ES8106177A1 (es) | Un procedimiento para la preparacion de nuevos antibioticos de milbecina. | |
KR920006360A (ko) | 스쿠알렌 합성효소 억제제 | |
KR890002214A (ko) | 데만노실 테이코플라닌 유도체 | |
KR860002574A (ko) | 항생물질 at 2433 복합체의 제조방법 | |
KR840002904A (ko) | 슈도모나스속의 미생물 및 수용액내에서 메틸그룹을 함유한 화합물을 분해시키는 방법 | |
ES480405A1 (es) | Un procedimiento para la obtencion de sustancias antibioti- cas o sus derivados. | |
GB1481529A (en) | Cephalosporin antibiotic substance and the production thereof | |
ES2080068T3 (es) | Derivados de 2-piranona y su procedimiento de preparacion. | |
ES2056967T3 (es) | Ws-9326a, ws-9326b y sus derivados. | |
KR890014457A (ko) | 신규 아족시 화합물 및 그의 제조방법 | |
RU2001116104A (ru) | Ванкорезмицин, способ его получения и его использование в качестве лекарственного средства | |
KR910014398A (ko) | 항생제 데옥시물룬도칸딘, 이의 제조방법 및 약제로서의 이의 용도 | |
EP0289804A3 (en) | Process for preparing optically active mercapto compound | |
KR880008972A (ko) | 카르복실산 유도체 | |
KR920002795A (ko) | 항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도 | |
ES2011462B3 (es) | Un procedimiento para la produccion de un glicosido de antraciclina. | |
DK0413967T3 (da) | Antibiotikum | |
KR910014509A (ko) | 항생성 알리사마이신, 이의 제조방법 및 용도 | |
JPS577479A (en) | Tetronolide compound | |
KR850006873A (ko) | 산성 폴리사이클릭 에테르 항생물질의 제조방법 | |
ES8304201A1 (es) | Un procedimiento para la preparacion de nuevas lactonas macrociclicas. | |
ATE48843T1 (de) | 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung. | |
FI841240A (fi) | Foerbaettringar i makrolidantibiotika. | |
GB1388198A (en) | Antibiotic fr-1923 and a process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |